New Commercial Model: Fact Vs. Fiction

As part of its ongoing analysis of trends in commercial operations in bio/pharma, TGaS Advisors has recently completed in-depth interviews and study of a broad cross-section of industry players, ranging from multinational pharmacos, to regional mid-size companies, to emerging biotechs. […]

Read More

Back to the Future With Track-and-Trace

 The past month or so has been an active one for followers of the never-ending track-and-trace debate in the industry. Following an FDA workshop in mid-February, the topic was front-and-center at March’s HDMA Distribution Conference (as it has been for […]

Read More

Pharma 2020: Supplying the Future

The pharmaceutical industry is experiencing major upheavals, as PwC US has noted in earlier papers in our Pharma 2020 series. Many companies have responded by focusing on discovering, developing and marketing medicines more efficiently; but to date they’ve invested less […]

Read More